Clinical trials
Active, not recruiting Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
226 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 16 |
| 2022 | 22 |
| 2023 | 28 |
| 2024 | 39 |
| 2025 | 36 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 226 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Gan & Lee Pharmaceuticals. | 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| DexCom, Inc. | 3 |
| Johns Hopkins University | 3 |
| Massachusetts General Hospital | 3 |
| National Taiwan University Hospital | 3 |
| University of Oxford | 3 |
| University of Pennsylvania | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 226 |
| Diabetes Mellitus, Type 2 | 40 |
| Obesity | 40 |
| Hypertension | 37 |
| Cardiovascular Diseases | 29 |
| Diabetes Mellitus, Type 1 | 24 |
| Overweight | 16 |
| Insulin Resistance | 12 |
| Heart Failure | 11 |
| Neoplasms | 11 |
Trials
Showing 1 to 25 of 226. Each trial links to its page on Pharma Observatory.
126 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.